• MOG (35-55): Reading EAE Through IFN-I Biology

  2026-10-05

  MOG (35-55) is a myelin oligodendrocyte glycoprotein peptide that provides an antigen-defined context for autoimmune encephalomyelitis research. This article interprets its value through the 2025 PARP7–STAT1/STAT2 study, emphasizing evidence boundaries, pathway biology, and translational relevance rather than experimental workflow.

• KX2-391 Dihydrochloride: Evidence Overview

  2026-10-05

  KX2-391 dihydrochloride, also called Tirbanibulin dihydrochloride, is discussed as a dual-mechanism Src and tubulin inhibitor with an established topical actinic keratosis context. A 2024 HeLa-cell study supports effects on proliferation, HPV-18 oncoprotein expression, oncogenic signaling, and apoptosis, while evidence for broader HPV, HBV, and BoNT/A applications remains more limited and indication-specific.

• Rice Stripe Virus NS3 and Host Kinase Signaling

  2026-10-04

  Zhuang et al. show that Rice stripe virus NS3 switches between distinct effects on host defense as infection progresses, linking NS3 phosphorylation to the OsSnRK3.25–OsCBL1/3–OsRBOHF pathway. The study provides a mechanistic model for how a plant virus balances pathogenicity, host or vector survival, and transmission rather than maximizing damage at every stage.

• L1023 Anti-Cancer Compound Library: Evidence Overview

  2026-10-03

  A source-grounded overview of the L1023 Anti-Cancer Compound Library, its potential role in cancer research, and the evidence surrounding capsazepine, MCL1 inhibition, and tamoxifen resistance.

• Linoleic Acid (C18:2): Practical Assay Guide

  2026-10-02

  Linoleic Acid (C18:2(9Z,12Z), SKU C3108) provides a defined lipid input for oxidative stress, membrane, erythrocyte, epithelial migration, and essential fatty acid studies. It is suited to freshly prepared ethanol- or DMSO-based workflows, but not to aqueous-only assays or experiments requiring long-term storage of prepared solutions.

• Capsazepine as an MCL1 Inhibitor in Breast Cancer

  2026-10-01

  The reference study identifies capsazepine as a previously unrecognized MCL1-binding compound that suppresses tamoxifen-resistant breast cancer cells. Through virtual screening, structural modeling, cellular assays, and DARTS-based target validation, the authors connect MCL1 inhibition with mitochondrial apoptosis and renewed tamoxifen sensitivity.

• PRX3 Targeting in Mesothelioma: Preclinical to Phase 1

  2026-10-01

  The reference study connects mitochondrial PRX3 dependence with mesothelioma growth, showing that genetic deletion and thiostrepton-based pharmacological inhibition disrupt tumor redox homeostasis. Its phase 1 findings provide an early clinical rationale for local PRX3 targeting, while SLC7A11 emerges as a candidate mediator of resistance.

• FPH1 (BRD-6125) Hepatocyte Assay Guide

  2026-09-30

  This scenario-based guide explains how FPH1 (BRD-6125) Hepatocyte Functional Proliferation Enhancer, SKU B3701, can help researchers distinguish hepatocyte expansion from functional maturation. It covers assay design, dosing, solubility, orthogonal readouts, and practical vendor-selection criteria for primary and iPS-derived hepatocyte workflows.

• Cell Counting Kit-8 (CCK-8) for Reliable Assays

  2026-09-30

  This scenario-driven guide explains how Cell Counting Kit-8 (CCK-8), SKU K1018, supports reproducible cell viability, proliferation, and cytotoxicity measurements. It covers WST-8 chemistry, controls, optimization, interpretation, and practical vendor-selection criteria for biomedical research.

• Protease Inhibitor Cocktail for Liver Protein Workflows

  2026-09-29

  Protect liver and macrophage proteins during disruption with an EDTA-free, broad-spectrum formulation suited to Western blotting, co-immunoprecipitation, kinase assays, and other cation-sensitive workflows. This guide connects practical sample handling with the macrophage and inflammasome findings reported in a Mallory-Denk body model.

• 2,7-Dichlorodihydrofluorescein diacetate ROS Workflow

  2026-09-29

  Build a practical DCFH-DA workflow for fluorescence microscopy, flow cytometry, and plate-based oxidative stress assays. The guide connects intracellular ROS measurement with the THBS1/PI3K/AKT findings in granulosa-cell research while emphasizing controls, normalization, and probe-specific limitations.

• Angiotensin I: From Precursor to Translation

  2026-09-28

  Angiotensin I is more than an intermediate in the renin-angiotensin system. As a defined ACE substrate, it enables researchers to separate peptide conversion from downstream receptor signaling and build more interpretable cardiovascular, neuroendocrine, and antihypertensive drug studies.

• Polygodial for TRPA1 Channel Research

  2026-09-28

  Use Polygodial to probe TRPA1-dependent calcium signaling, then connect channel activation to NFAT localization and epithelial inflammatory readouts. This workflow turns a channel-level response into a testable signaling sequence while emphasizing controls that distinguish TRPA1 effects from solvent, cell-state, and downstream pathway effects.

• Natural-Product Screening Identifies NSP15 Binders

  2026-09-27

  Vijayan and Gourinath used structure-based virtual screening and molecular dynamics to prioritize thymopentin and oleuropein as candidate binders of the SARS-CoV-2 endoribonuclease NSP15. The results provide a computational starting point for inhibitor testing, but do not establish antiviral activity or clinical efficacy.

• DAF-2 Diacetate for Nitric Oxide Imaging

  2026-09-26

  DAF-2 diacetate turns intracellular NO-related chemistry into a retained fluorescent readout for live cells and complex tissues. Applied to soybean nodules, it can complement sulfur-transport and senescence measurements—but fluorescence should be interpreted as a pathway-sensitive signal, not a direct NO concentration.

8433 records 1/563 page Next 12345 下5页 Last page